Insider Shareholders with Direct Ownership of Harrow Health, Inc. (HROW)
This section provides a comprehensive overview of the insiders with direct ownership of Harrow Health, Inc. (HROW). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
HARROW HEALTH, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mark L Baum
CHIEF EXECUTIVE OFFICER |
2,418,000 | 918,151 | 2,137,525 $90.3 Million | 18 |
Mar 22, 2024
Added 0.42%
|
|
Andrew R. Boll
CHIEF FINANCIAL OFFICER |
721,900 | 276,811 | 568,089 $24 Million | 16 |
Feb 20, 2024
Reduced 3.15%
|
|
John P. Saharek
CEO of ImprimisRx |
472,200 | 202,537 | 299,663 $12.7 Million | 11 |
Sep 11, 2024
Reduced 13.09%
|
|
Anthony Principi
Director |
93,798 | 0 | 93,798 $3.96 Million | 1 |
Sep 28, 2020
Added 50.0%
|
|
Martin A. Makary
Director |
45,000 | 0 | 45,000 $1.9 Million | 2 |
Aug 14, 2023
Added 30.77%
|
|
R. Lawrence Van Horn
Director |
1,860 | 0 | 1,860 $78,566 | 1 |
Dec 22, 2022
Added 50.0%
|